M.D., MPH, M.B.A., Chief Medical Officer, Lunit
Brandon studied medicine in Seoul National University College of Medicine and is a board certified physician in Family Medicine, trained at Seoul National University Hospital. Prior to medical school, he graduated from KAIST with a bachelor’s degree in Biological Sciences. He has also received master’s degrees in both Public Health (MPH) and Business Administration (MBA). Brandon has a deep passion for medical research with much experience in both basic and clinical research, having published 30+ articles in world-renowned journals like Hepatology and Annals of Oncology.
AI & Data Science Showcase: Lunit Inc.
Lunit, abbreviated from “learning unit,” is a Medical AI software company devoted to developing advanced medical image analytics and novel imaging biomarkers via cutting-edge deep learning technology. Lunit’s products in chest, breast, cardiac radiology, as well as digital pathology, are primarily focused on augmenting interpretive accuracy of clinicians and preventing unnecessary diagnostic tests and treatment.
Perfecting Intelligence, Transforming Medicine: Novel AI-powered Imaging Biomarkers to Guide Precision Diagnostics and Treatment
Lunit thrives to expand the boundaries of AI-driven capabilities for medical image analytics, focused on delivering unprecedented diagnostic and therapeutic imaging biomarkers for breast and lung cancer, clinically translated into prevention of unnecessary tests and treatment. Lunit’s products that feature its state-of-the-art deep learning technology trained with large-scale high quality data will be introduced, including results from its most recent clinical studies.